| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000020199 |
| Receipt No. | R000023329 |
| Official scientific title of the study | Hypofractionated proton beam therapy for localized prostate cancer |
| Date of disclosure of the study information | 2015/12/15 |
| Last modified on | 2017/06/30 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Hypofractionated proton beam therapy for localized prostate cancer | |
| Title of the study (Brief title) | Hypofractionated proton beam therapy for localized prostate cancer | |
| Region |
|
|
| Condition | ||
| Condition | Prostate cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To confirm the feasibility and efficacy of hypofractionated proton beam therapy for localized prostate cancer |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | 5-year rate of Grade 2 or worse late toxicity |
| Key secondary outcomes | Acute and late toxicity rate, biochemical relapse-free rate, overall survival rate, cause-specific survival rate, and clinical relapse-free survival rate at 5 years |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 67.5GyE in 25 fractions with a fractional dose of 2.7Gy | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1) Pathologically proven adenocarcinoma of the prostate
2) cT1c-T4N0M0(UICC 7th) Prostate cancer 3) ECOG-PS 0-2 4) Age 20-yrs old or over at the time of consent form is obtained 5) Well informed and documented consent from the patient |
|||
| Key exclusion criteria | 1) With active other cancers
2) With severe uncontrolled diabetes 3) With severe heart disease, or some serious complications, i.e., SLE, Scleroderma, interstitial pneumonia 4) Allergic to radiation 5) Previous surgical treatment for prostate disease before enrollment 6) Previous chemotherapy (except holmonal therapy)for prostate cancer before enrollment 7) Previous radiotherapy to pelvis 8) With implantable cardioverter defibrillator or permanent pacemaker 9) Considered that participation in this trial is difficult because of psychiatric symptoms or psychosis 10) Cannot be held rest for about 60 minutes 11) Cannot be implanted Au marker in the prostate 12) Unsuitable for enrollment judged by principal investigator |
|||
| Target sample size | 120 | |||
| Research contact person | |
| Name of lead principal investigator | Katsunori Tauchi |
| Organization | Aizawa hospital |
| Division name | Comprehensive Cancer Center |
| Address | 2-5-1 Honjou Matsumoto-City, Nagano 390-8510 JAPAN |
| TEL | +81-263-33-8600 |
| ai.65718@ai-hosp.or.jp | |
| Public contact | |
| Name of contact person | Masayuki Araya |
| Organization | Aizawa hospital |
| Division name | Proton therapy center |
| Address | 2-5-1 Honjou Matsumoto-City, Nagano 390-8510 JAPAN |
| TEL | +81-263-33-8600 |
| Homepage URL | |
| ai.65718@ai-hosp.or.jp | |
| Sponsor | |
| Institute | Aizawa hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Aizawa hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 相澤病院(長野県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023329 |